Business model
Through our global network involving pharmaceutical companies and other entities, we understand the requirements of physicians and patients, such as the QOL needs, and develop drug formulations by combining our proprietary technologies. While developing medical products by ourselves until proof-of-concept (superiority of medical products) is demonstrated, we aim to form partnerships with pharmaceutical companies (development and sales partners). To help pharmaceutical companies develop new medical products, we also offer business solutions to develop optimal transdermal formulations.
If you have the following needs, please contact us.
- Improvement of original transdermal formulations
To reduce skin irritation
To weaken or strengthen the adhesiveness
- Development of new transdermal formulations
To improve drug permeability
To adjust duration of drug administration
R&D Plan
We prepare prototypes and establish proof-of-concept in small animals. We cooperate with our clients in clinical development and GMP manufacturing.